dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


  1. 2022
  2. Published

    Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review

    Dodick, D. W., Goadsby, P. J., dlt446, dlt446, Tassorelli, C., Hundemer, H., Bardos, J. N., Wenzel, R., Kemmer, P., Conley, R., Martinez, J. M. & Oakes, T., 2022, In: Headache. 62, 4, p. 453-472 20 p.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Clinical characteristics of combined rosacea and migraine

    Wienholtz, N. K. F., Christensen, C. E., Zhang, D. G., Rechnagel, A. S. A., Byrnel, H. V. S., Haugaard, J. H., dlt446, dlt446, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2022, In: Frontiers in Medicine. 9, 1026447.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Cluster headache – The worst possible pain on YouTube

    Chaudhry, B. A., Do, T. P., Ashina, H., dlt446, dlt446 & Amin, Faisal Mohammad, 2022, In: Headache. 62, 9, p. 1222-1226 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Debate: Are cluster headache and migraine distinct headache disorders?

    Al-Karagholi, M. A. M., Peng, K., Petersen, A. S., De Boer, I., Terwindt, G. M. & dlt446, dlt446, 2022, In: Journal of Headache and Pain. 23, 13 p., 151.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Editorial introductions

    Hartung, H., dlt446, dlt446 & Volpe, B. T., 2022, In: Current Opinion in Neurology. 35, 3, 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  7. Published

    Effect of K-ATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic

    Kokoti, L., Al-Karagholi, M. A., Elbahi, F. A., Coskun, H., Ghanizada, H., Amin, Faisal Mohammad & dlt446, dlt446, 2022, In: Cephalalgia. 42, 9, p. 846-858 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2

    dlt446, dlt446, McAllister, P., Cady, R., Hirman, J. & Ettrup, A., 2022, In: Cephalalgia. 42, 8, p. 696-704 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

    Sacco, S., Amin, Faisal Mohammad, dlt446, dlt446, Bendtsen, Lars, Deligianni, C. I., Gil-Gouveia, R., Katsarava, Z., MaassenVanDenBrink, A., Martelletti, P., Mitsikostas, D. D., Ornello, R., Reuter, U., Sanchez-del-Rio, M., Sinclair, A. J., Terwindt, G., Uluduz, D., Versijpt, J. & Lampl, C., 2022, In: Journal of Headache and Pain. 23, 19 p., 67.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention

    Lipton, R. B., Goadsby, P. J., Dodick, D. W., McGinley, J. S., Houts, C. R., Wirth, R. J., Kymes, S., Ettrup, A., Østerberg, O., Cady, R., dlt446, dlt446 & Buse, D. C., 2022, In: Headache. 62, 6, p. 690-699 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition

    Schwedt, T. J., Tassorelli, C., Silberstein, S. D., Szperka, C. L., Kurth, T., Pozo-Rosich, P., Amin, Faisal Mohammad, Lipton, R. B., Dodick, D. W., dlt446, dlt446, Diener, H. & Terwindt, G. M., 2022, In: Cephalalgia. 42, 11-12, p. 1099-1115 17 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 12 3 4 5 6 7 8 9 ...37 Next

ID: 920785